These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34655576)

  • 1. Neurotoxicity of MDMA: Main effects and mechanisms.
    Costa G; Gołembiowska K
    Exp Neurol; 2022 Jan; 347():113894. PubMed ID: 34655576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans.
    Green AR; King MV; Shortall SE; Fone KC
    Br J Pharmacol; 2012 Jul; 166(5):1523-36. PubMed ID: 22188379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms.
    Moratalla R; Khairnar A; Simola N; Granado N; García-Montes JR; Porceddu PF; Tizabi Y; Costa G; Morelli M
    Prog Neurobiol; 2017 Aug; 155():149-170. PubMed ID: 26455459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response.
    Green AR; O'shea E; Colado MI
    Eur J Pharmacol; 2004 Oct; 500(1-3):3-13. PubMed ID: 15464016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity.
    Monks TJ; Jones DC; Bai F; Lau SS
    Ther Drug Monit; 2004 Apr; 26(2):132-6. PubMed ID: 15228153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Magnetic Resonance Imaging in Abstinent MDMA Users: A Review.
    Garg A; Kapoor S; Goel M; Chopra S; Chopra M; Kapoor A; McCann UD; Behera C
    Curr Drug Abuse Rev; 2015; 8(1):15-25. PubMed ID: 25731754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').
    McCann UD; Slate SO; Ricaurte GA
    Drug Saf; 1996 Aug; 15(2):107-15. PubMed ID: 8884162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological and cognitive alterations induced by MDMA in humans.
    Montgomery C; Roberts CA
    Exp Neurol; 2022 Jan; 347():113888. PubMed ID: 34624331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
    Alves E; Summavielle T; Alves CJ; Custódio JB; Fernandes E; de Lourdes Bastos M; Tavares MA; Carvalho F
    Addict Biol; 2009 Apr; 14(2):185-93. PubMed ID: 19076925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDMA and 5-HT neurotoxicity: the empirical evidence for its adverse effects in humans - no need for translation.
    Parrott AC
    Br J Pharmacol; 2012 Jul; 166(5):1518-20; discussion 1521-2. PubMed ID: 22404300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain serotonin transporter binding in former users of MDMA ('ecstasy').
    Selvaraj S; Hoshi R; Bhagwagar Z; Murthy NV; Hinz R; Cowen P; Curran HV; Grasby P
    Br J Psychiatry; 2009 Apr; 194(4):355-9. PubMed ID: 19336788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies.
    McCann UD; Eligulashvili V; Ricaurte GA
    Neuropsychobiology; 2000; 42(1):11-6. PubMed ID: 10867551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of free radicals in MDMA-induced neurotoxicity in mice.
    Cadet JL; Thiriet N; Jayanthi S
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS57-9. PubMed ID: 11435997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms.
    Lyles J; Cadet JL
    Brain Res Brain Res Rev; 2003 May; 42(2):155-68. PubMed ID: 12738056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,4-methylenedioxymethamphetamine (MDMA): a review.
    O'Leary G; Nargiso J; Weiss RD
    Curr Psychiatry Rep; 2001 Dec; 3(6):477-83. PubMed ID: 11707161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users.
    Parrott AC; Milani RM; Gouzoulis-Mayfrank E; Daumann J
    J Neural Transm (Vienna); 2007; 114(8):959-68. PubMed ID: 17520319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves.
    Parrott AC
    Neuropsychobiology; 2004; 50(4):329-35. PubMed ID: 15539865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ecstasy toxicity].
    Reingardiene D
    Medicina (Kaunas); 2006; 42(6):519-23. PubMed ID: 16816548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.
    Capela JP; Carmo H; Remião F; Bastos ML; Meisel A; Carvalho F
    Mol Neurobiol; 2009 Jun; 39(3):210-71. PubMed ID: 19373443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.